Answers are grounded in this paper and cite their sources.
Ebola Hemorrhagic Fever (EHF) is a rare viral disease, caused by infection with Ebola virus. It is characterized by abrupt onset of fever, chills, malaise, gastrointestinal, respiratory, cutaneous, and central nervous system manifestations. In 2014, the World Health Organization (WHO) declared the outbreak of EHF to be a Public Health Emergency of International Concern. Up to now, no specific therapeutics or vaccines have been approved for this lethal disease.
No takes yet. Share an insight, caveat, or question.
A 2015 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: